mberkner@cooley.com
Michal leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including deSPACs, reverse mergers, negotiated and unsolicited transactions, and joint ventures. Her clients include strategic and private equity buyers and sellers in public and private transactions. She is dual qualified in New York and England and Wales.
Download full bio
Redx Pharma to Merge With Jounce Therapeutics
Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
View all
Mergers & Acquisitions
Private Equity
Life Sciences
Technology
Israel
Outstanding. Smart, can-do and entrepreneurial attitude. Always available, very commercial, and a pleasure to work with.
University of Pennsylvania Law SchoolJD, 1997
Johns Hopkins UniversityBA, 1994
England & Wales
New York
VectivBio to be Acquired by Ironwood May 23, 2023
Redx Pharma to Merge With Jounce Therapeutics February 24, 2023
Bavarian Nordic Acquires Emergent BioSolutions’ Travel Vaccines Portfolio February 16, 2023
The Legal 500 UK: M&A (2022) Chambers & Partners (UK): Leading Individual - Corporate/ M&A (2022)
Schemes of Arrangement: Dodgy Plots or Effective Ways to Purchase UK Companies?
Life Sciences Reverse Mergers Go Global: Is it the Path for Your Company?
Cross-Border M&A: 10 Key Trends From Across the Pond
Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties
Social Distancing From a (Supposed) Life Partner: Early Lessons From Deals Terminated and On the Rocks in the COVID-19 Era
Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks
Cooley’s 2019 Tech M&A Year in Review
Cooley's 2019 Life Sciences M&A Year in Review
Taking a Play out of the Financial Acquirer’s Playbook
Use of Earn-Outs to “Bridge” the Valuation Gap
+44 (0) 20 7556 4321
Locations